Shanghai, China – February 5, 2026 – Insight Lifetech, a leading innovator in the cardiovascular field, marked a historic milestone today as it officially rang the listing bell at the Shanghai Stock Exchange (SSE), kicking off its journey as a publicly traded company and reinforcing its commitment to its core mission: “To Transform Healthcare through Innovation and Quality.”

The bell-ringing ceremony, attended by company executives, key investors, core team members, and industry partners, was more than a symbolic moment—it was a testament to Insight Lifetech’s unwavering dedication over the years to developing cutting-edge medical solutions that address unmet clinical needs.

Since its founding, Insight Lifetech has distinguished itself through its focus on clinically driven innovation and adherence to the highest quality standards in every product and solution it develops. The company’s successful listing on the SSE is a recognition of its technological strength, business potential, and the value it brings to the healthcare industry. It also opens new avenues for collaboration, enabling Insight Lifetech to partner with more industry leaders, expand its global footprint, and drive greater progress in healthcare transformation.

With support from the capital markets, Insight Lifetech will continue to prioritize innovation, deepen its research in cardiovascular fields, and launch more high-quality products that improve patient access to advanced healthcare.

About Insight Lifetech

Insight Lifetech is a leading innovative medtech company dedicated to transforming precision diagnosis and treatment in cardiovascular and other critical healthcare areas. Founded with a commitment to “To Transform Healthcare through Innovation and Quality,” the company focuses on developing clinically relevant, high-quality medical solutions that improve patient outcomes. With a strong R&D team, advanced manufacturing capabilities, and a customer-centric approach, Insight Lifetech is at the forefront of driving healthcare innovation and shaping the future of medical technology.